NASDAQ:MDCX Medicus Pharma Earnings Date & Estimates $3.25 -0.18 (-5.25%) Closing price 04:00 PM EasternExtended Trading$3.39 +0.14 (+4.37%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Medicus Pharma is estimated to report earnings on Friday, November 13, 2026, before market opens. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement Announcement DateNovember 13, 2026TimeBefore Market Opens Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Medicus PharmaMedicus Pharma is expected to post earnings of -$6.6250 per share. In the same quarter a year earlier Medicus Pharma reported -$32.50 per share. Medicus Pharma last reported on August 12, 2026, posting -$10.50 per share and missing the -$6.3750 consensus estimate. Medicus Pharma has beaten the consensus EPS estimate in 1 of its last 7 quarters.Consensus EstimatesConsensus EPS-$6.6250Prior-Year EPS-$32.50Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$10.50 (Missed by -$4.1250)EPS Beat Rate1 of last 7 quartersPrepare for the Earnings CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Medicus Pharma Earnings FAQ When does Medicus Pharma report earnings? Medicus Pharma (NASDAQ:MDCX) is estimated to report earnings on Friday, November 13, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What is the consensus EPS estimate for Medicus Pharma? Analysts expect Medicus Pharma to post earnings of -$6.6250 per share for the quarter. Medicus Pharma Earnings HeadlinesMedicus Pharma Announces Nasdaq-Compliant Share ConsolidationOctober 16 at 5:30 PM | tipranks.comMedicus Charts Multi-Asset Growth Strategy After Three Years Of Expansion; Stock DownOctober 8, 2026 | rttnews.comSpaceX minted 4400 millionaires in a single daySpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into millionaires. One welder's $10,000 stock package made him a millionaire on IPO day. Former Wall Street CEO Dylan Jovine says Elon Musk's next venture could outsize everything he's built before. It runs on an obscure AI firm Musk has relied on since 2012, supplying crucial technology to Tesla, Starlink and SpaceX.October 16 at 1:00 AM | Behind the Markets (Ad)Medicus Pharma Outlines Clinical Development Strategy Across Three Drug Programs Following $90 Million in FinancingOctober 8, 2026 | finance.yahoo.comMedicus Pharma targets partnerships and clinical milestones as oncology pipeline advancesOctober 8, 2026 | proactiveinvestors.comMedicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term ValueOctober 8, 2026 | globenewswire.comSee More Medicus Pharma Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Medicus Pharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medicus Pharma and other key companies, straight to your email. Email Address About Medicus PharmaMedicus Pharma (NASDAQ:MDCX). is a life sciences company focused on acquiring, developing and commercializing innovative therapeutic and medical device technologies. Its activities are centered primarily on wound care, dermatology and related areas of medical treatment. The company’s portfolio includes Natrox® Oxygen Wound Therapy, a device designed to deliver continuous topical oxygen to the wound site. The technology is intended to support the treatment of chronic and hard-to-heal wounds and may be used in clinical and home-care settings, subject to applicable regulatory approvals. Medicus Pharma serves healthcare markets through the commercialization of its technologies and partnerships with medical professionals and distribution networks. Publicly available information about the company’s broader operations, geographic reach and leadership is limited.View Medicus Pharma ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Bank of America Stock Sell-Off Looks Like a Buying OpportunityMorgan Stanley Beats on Earnings, But Shares Fall on Trading MixFundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?Palantir's Potential Next Catalyst After Retail Profit-TakingApple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure Upcoming Earnings HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
